Back to diagnoses

What is generalized anxiety disorder?

Generalized anxiety disorder is an anxiety disorder disorder characterized by persistent, unrealistic, and excessive anxiety and worry over every day activities. The median age of onset of GAD is 31 years, and individuals from developed countries are more likely to develop GAD than individuals from non-developed countries. Women are 2-3 times more likely to develop GAD than men.

What does GAD look like?

Risk Factors

  • Temperamental factors such as behavioral inhibition, high neuroticism, and harm avoidance
  • Adverse childhood events
  • Parental overprotection
  • Low socioeconomic status
  • Family history of anxiety disorders

Psychological theories of GAD:

  • Psychodynamic: conflict between the id, ego, and superego leads to anxiety
  • Cognitive: distorted thinking patterns lead to dysfunctional appraisal of situations

Differential Diagnosis

  • Anxiety disorder due to another medical condition
  • Substance/medication-induced anxiety disorder
  • Social anxiety disorder
  • Obsessive-compulsive disorder
  • Post-traumatic stress disorder
  • Adjustment disorder
  • Depressive disorders
  • Bipolar disorders
  • Psychotic disorders
  • Other childhood disorders

How is GAD investigated?

  • Labwork: CBC, fasting glucose, fasting lipid profiles, electrolytes, liver enzymes, serum bilirubin, serum creatinine, thyroid stimulating hormone (TSH)
  • Urinalysis, urine toxicology for substance use
Screening/Scale Rater Description
Generalized Anxiety Disorder 7 (GAD-7) Client 7 questions for screening, with severity measure for general anxiety disorder
Beck Anxiety Inventory (BAI) Client

21 questions for screening, with severity measure for general anxiety disorder

How is GAD treated?

First-line medications:

  • Melatonin agonists: agomelatine
  • Anticonvulsant: pregabalin
  • Selective serotonin reuptake inhibitors: escitalopram, paroxetine, paroxetine CR, sertraline
  • Serotonin-norepinephrine reuptake inhibitors (SNRI): duloxetine, enlafaxine XR

Second-line medications:

  • Benzodiazepines: alprazolam, bromazepam, diazepam, orazepam
  • Norepinephrine and dopamine reuptake inhibitors (NDRI): bupropion XL
  • Anxiolytics: buspirone
  • Antihistamines: hydroxyzine
  • Tricyclic antidepressants: imipramine
  • Atypical antipsychotics: quetiapine XR
  • Selective serotonin reuptake inhibitors: vortioxetine

Third-line medications:

  • Selective serotonin reuptake inhibitors (SSRI): citalopram, fluoxetine
  • Anticonvulsants: divalproex chrono
  • Tetracyclic antidepressants: mirtazapine
  • Serotonin agonist and reuptake agonists (SARI): trazodone

Special Considerations

Children & Teenagers

Psychotherapy should always be the first option for treatment of GAD in youth. Cognitive behavioral therapy has proven to be effective when it is adjusted to the developmental level of the child. Parental involvement in psychotherapy treatment for children is also beneficial.

Older Adults

Older adults with GAD report greater severity of sleep disturbance compared to any other age group diagnosed with GAD.

The fear of falling is correlated with GAD and anxiety symptoms in general.

Nursing Management

Causes & Behaviors:

  • Excessive worrying
  • Difficulty concentrating; decreased attention span
  • Feeling discomfort, apprehension, or helplessness
  • Restlessness, hyperactivity, or pacing
  • Impulsivity
  • Inability to discriminate harmful stimuli or situations

Interventions:

  • Maintain a calm, non threatening manner while working with the client
  • Reduce stimuli in the environment
  • Provide reassurance and comfort measures
  • Offer PRN medications for high levels of anxiety, and monitor for side effects
  • Encourage client to participate in relaxation techniques

References

[1] American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA.

[2] Boyd, M. A. (2019). Psychiatric & mental health nursing for Canadian practice. Wolters Kluwer.

[3] Bradford, A., PhD., Cully, J., PhD., Rhoades, H., PhD., Kunik, Mark,M.D., M.P.H., Kraus-Schuman, C., Wilson, Nancy, M.A., L.M.S.W., & Stanley, M., PhD. (2011). Early response to psychotherapy and long-term change in worry symptoms in older adults with generalized anxiety disorder. The American Journal of Geriatric Psychiatry, 19(4), 347-56. 

[4] Brenes, G. A., PhD., Miller, M. E., PhD., Stanley, M. A., PhD., Williamson, J. D., M.D., Knudson, M., M.D., & McCall, W. V. (2009). Insomnia in older adults with generalized anxiety disorder. The American Journal of Geriatric Psychiatry, 17(6), 465-72. 

[5] Payette, M., Bélanger, C., Benyebdri, F., Filiatrault, J., Bherer, L., Bertrand, J., Nadeau, A., Bruneau, M., Clerc, D., Saint-Martin, M., Cruz-Santiago, D., Ménard, C., Nguyen, P., Vu, T. T. M., Comte, F., Bobeuf F., & Grenier , S. (2017). The association between generalized anxiety disorder, subthreshold anxiety symptoms and fear of falling among older adults: Preliminary results from a pilot study. Clinical Gerontologist, 40(3), 197-206.

[6] Payne, S., Bolton, D., & Perrin, S. (2011). A pilot investigation of cognitive therapy for generalized anxiety disorder in children aged 7-17 years. Cognitive Therapy and Research, 35(2), 171-178. https://doi.org/10.1007/s10608-010-9341-z

[7] Townsend, M. C. (2015). Psychiatric mental health nursing. F.A. Davis.